Freely Filtered 054: EMPA-Kidney. EMPA-Kidney is the last of the big three to report their Kidney Endpoints SGLT2i trial (CREDENCE for Cana, DAPA-CKD for Dapa, and now EMPA-Kidney for Empa) and it answers some questions that had previously been unanswered. Join the Filtrate as they tear it apart.
Freely Filtered 053: The Kidney Week Draft
Freely Filtered 052: Acetazolamide for Acute Decompensated Heart Failure (ADVOR)
Freely Filtered 051: Pip Tazo and Vanco: Nephrotoxin or Not so toxic
Freely Filtered 050: CLASSIC Trial
Freely Filtered 049: Getting Salty with SODIUM-HF
Freely Filtered 048: Putting TESTING to the Test
Episode 048: TESTING is the latest IgA nephropathy trial and it is the comeback kid of nephrology trials. From a trial that was halted because of excess adverse events to a safe and effective therapy with just a few tweeks. Amazing turn around. Join the Filtrate as we put TESTING to the test with study author Sean Barbour.
Freely Filtered 047: CHAP, time to treat hypertension in pregnancy
Freely Filtered 046: The ISPD Peritonitis Guideline Draft
Freely Filtered 045: Salt Substitution and Stroke Study (SSaSS)
Freely Filtered 044: Pigs on the Wing: Xenotransplantation
Freely Filtered 043: NephMadness and Animal House
Freely Filtered 042: Nephrin Antibodies Cause Minimal Change Disease. Wait...What?
Freely Filtered 041: Top Nephrology Stories of 2021
Episode 041: Matt Sparks and The Renal Fellow Network has been polling the community about the top nephrology stories of the year since 2010. Matt joins Swap and Joel to discuss the top stories of 2021.
Freely Filtered 040: Double CLICK for BP control in CKD stage 4
Freely Filtered 039: The First Annual ASN #KidneyWk Draft
Freely Filtered 038: AURORA1, a new treatment for Lupus Nephritis
Freely Filtered 037: The first Guideline Draft: KDIGO Hypertension Guidelines
Freely Filtered 036: AKIKI-2, How soon is now?
Episode 036 AKIKI-2. Nephrology has been the beneficiary of a handful of studies examining the impact of the timing of the initiation of dialysis in AKI. One of these trials, AKIKI, now has a genuine sequel. In 2016 AKIKI was the first multi-center RCT examining early initiation of dialysis versus late initiation of dialysis and showed that early initiation not only failed to improve patient outcomes but resulted in a significant number of patients receiving dialysis that would have recovered kidney function without intervention had they only been randomized to the late arm. Now five years later we are reviewing the sequel which asks the next logical question, “If delayed dialysis is as good as early dialysis is even later dialysis equivalent or even better?”
Freely Filtered 035: ASN Fellow Survey, COVID-19 Edition
Episode 035: The COVID-19 Pandemic changed everything and last fall the ASN set out to document how it affected our nephrology fellows. The ASN Workforce Committee adapted the Annual Fellow Survey to assess how the pandemic affected nephrology fellows in terms of burn out, education, and enthusiasm for the specialty.